Wei-Li Shao Sells 8,866 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) President Wei-Li Shao sold 8,866 shares of Omada Health stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $25.02, for a total value of $221,827.32. Following the sale, the president directly owned 307,372 shares in the company, valued at approximately $7,690,447.44. This trade represents a 2.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Wei-Li Shao also recently made the following trade(s):

• On Friday, June 12th, Wei-Li Shao sold 4,589 shares of Omada Health stock. The stock was sold at an average price of $17.24, for a total value of $79,114.36.

Omada Health Trading Up 2.2%

Shares of NASDAQ:OMDA opened at $24.37 on Friday. The firm has a market capitalization of $1.49 billion, a PE ratio of 487.40 and a beta of 1.73. Omada Health, Inc. has a 1-year low of $10.28 and a 1-year high of $26.92. The business’s 50 day moving average is $20.87 and its 200-day moving average is $16.43.

Omada Health (NASDAQ:OMDA) last issued its earnings results on Thursday, August 6th. The company reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. The business had revenue of $87.83 million during the quarter, compared to analyst estimates of $80.93 million. Omada Health had a return on equity of 2.67% and a net margin of 1.39%. On average, sell-side analysts predict that Omada Health, Inc. will post -0.01 EPS for the current year.

Hedge Funds Weigh In On Omada Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Raymond James Financial Inc. bought a new stake in Omada Health during the second quarter worth about $32,000. Bellevue Group AG boosted its holdings in shares of Omada Health by 0.7% in the 3rd quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock worth $5,567,000 after acquiring an additional 1,791 shares in the last quarter. Quarry LP acquired a new position in shares of Omada Health in the 4th quarter worth approximately $29,000. Barclays PLC boosted its stake in Omada Health by 14.6% in the fourth quarter. Barclays PLC now owns 14,850 shares of the company’s stock worth $234,000 after purchasing an additional 1,888 shares in the last quarter. Finally, TD Waterhouse Canada Inc. acquired a new stake in shares of Omada Health in the fourth quarter valued at $32,000.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Morgan Stanley reissued an “overweight” rating and issued a $30.00 target price on shares of Omada Health in a research note on Monday, June 22nd. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Omada Health in a report on Friday, May 8th. BTIG Research upped their price objective on Omada Health from $30.00 to $35.00 and gave the company a “buy” rating in a research note on Monday. Evercore reissued an “outperform” rating and issued a $20.00 target price on shares of Omada Health in a report on Friday, May 8th. Finally, Citigroup restated an “outperform” rating on shares of Omada Health in a research report on Monday, July 20th. Eleven investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $25.75.

Key Stories Impacting Omada Health

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Q2 results exceeded expectations. Omada reported adjusted earnings of $0.08 per share, compared with analysts’ expectation of a $0.02 loss, while revenue of approximately $87.8 million topped the $80.9 million consensus estimate. The results suggest growth in its digital chronic-care platform is increasingly converting into profitability. Omada Health Q2 earnings analysis
• Positive Sentiment: Several analysts raised their targets. Robert W. Baird lifted its price target from $15 to $25, while maintaining a neutral rating. Other recent targets include $27 from Citizens JMP and $35 from BTIG. The broader analyst consensus remains “Moderate Buy,” with an average target around $25.67–$25.75.
• Positive Sentiment: Institutional ownership increased. Perceptive Advisors and BlackRock reportedly initiated positions, Millennium Management expanded its stake, and Versant Capital Management increased its holdings by more than 300%. These moves may reinforce investor confidence in Omada’s growth outlook.
• Neutral Sentiment: Baird’s neutral stance highlights limited near-term upside. Its $25 target is only modestly above the recent trading level, suggesting the earnings beat and growth prospects may already be substantially reflected in the stock price.
• Negative Sentiment: Multiple senior executives sold shares. CEO Sean Duffy sold 8,628 shares, CFO Steven Cook sold 16,842 shares across two transactions, President Wei-Li Shao sold 8,866 shares, and Chief Accounting Officer Craig Gracey sold 1,042 shares. Although these sales may reflect personal liquidity or compensation planning, concentrated selling near $25 can weigh on sentiment. Omada Health insider trading report
• Negative Sentiment: Valuation risk remains elevated. Omada’s market capitalization is approximately $1.5 billion, while its reported price-to-earnings ratio is above 475. With the shares close to their 52-week high, any slowdown in revenue growth or profitability could prompt profit-taking.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.